bullish
Takeda and Shire Shareholders Unanimously Agree to $64b Deal
396 Views09 Dec 2018 22:56
Our take…
Reiterating our positive view, we think the deal could help Takeda on several fronts, including:
Sizeable footprint in the strategically...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Taisho Frontrunner to Acquire BMS’s French OTC Business18 Dec 2018
- Japan Pharma - Top Picks18 Dec 2018
- Takeda and Shire Shareholders Unanimously Agree to $64b Deal09 Dec 2018
- Pessimism Overdone: Takeda Undervalued By 40% Under Modestly Enhanced Post-Deal Financial Assumption16 Jul 2018
- Takeda Acquires Shire for US$64 Billion – We Continue Our Support of the Deal08 May 2018
x